Although many have touted strategies from travel avoidance to Tamiflu to halt the spread of H1N1 flu or swine flu, a large body of evidence from the Cochrane Library suggests that concentrating on children’s hygiene might be the best way to reduce the spread of respiratory illnesses.
“The evidence in children is clear. Handwashing offers protection against a lot of things, not just respiratory viruses,” said lead review author Tom Jefferson, MD.
Although the Centers for Disease Control and Prevention (CDC) cannot say how H1N1 flu spreads definitively, the CDC suggests that like the seasonal flu, the H1N1 flu spreads from person to person through sneezing and coughing.
Led by Jefferson, a medical epidemiologist at the Vaccines Field of the Cochrane Collaboration in Rome, researchers identified 51 studies examining a variety of interventions to contain respiratory virus epidemics, including influenza.
The updated review appears in the latest issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews like this one draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.
Frequent handwashing, using gloves, gowns and masks with filtration, and isolating people believed to be sick effectively reduced transmission of viral respiratory diseases, the authors found. The greatest potential for preventing disease spread was not among adults, though.
Children “are the least hygienic beings among us, but they are also the most social beings. Acting on children is probably the best, most effective intervention,” Jefferson said.
One large study in the review, conducted in 2005, examined rates of respiratory disease among 4,332 children in poor Pakistani households. Children who washed their hands several times daily with plain or antibacterial soap experienced 50 percent fewer episodes of respiratory illness, such as pneumonia or cough, compared to children with standard hygiene practices.
Other studies showed that younger children who received hand-washing instruction at school or home experienced significant decreases in respiratory illness. One study also found that school absenteeism dropped 43 percent when children used alcohol gels in conjunction with handwashing.
“It’s not surprising and it is useful to identify that children could be a source. Transmission occurring among children frequently can be the source of transmission to older people,” said Yvonne Maldonado, MD, chief of the division of pediatric infectious diseases at the Stanford University School of Medicine. “In terms of the H1N1 situation, I think a lot of their findings are applicable,” she said.
The review also examined evidence from a small study, involving only six volunteers, suggesting paper surgical masks may not be as effective a barrier to flu virus as the thicker N95 mask. Even when participants wore up to five layers of paper surgical masks, they were not able to prevent the spread of infected droplets as well as N95 facemasks. N95 facemasks are a type of respirator designed to block 95 percent of very small airborne particles, but they are expensive, hot, uncomfortable, and unable to be worn by children.
When it comes to facemasks, “It’s always been a tradeoff between performance and protection. The longer you wear them, the hotter you get and the more difficult it is to concentrate. Based on a small study done to examine experimental effects in lab, wearing them protects,” against virus, Jefferson said, but added that masks are impractical for use over long time periods.
“There is some controversy about whether or not N95 facemasks solve the problem, but there’s not one thing that will solve all the problems. We do know that if anything, these kinds of barriers keep people isolated and may reduce contamination,” Maldonado said.
“While there are not a lot of data to support certain interventions, there are not data to support that they shouldn’t be used either,” Maldonado said.
What about antiviral influenza drugs, such as Tamiflu?
Jefferson, who recently updated a 2009 Cochrane review on antiviral influenza drugs, commented that these drugs “don’t prevent influenza, but prevent symptoms if taken [as a precaution]. They appear to interrupt transmission in families and shorten the duration of illness just over a day provided they’re taken within 48 hours of symptoms appearing,” Jefferson said.
“But they cost a lot of money, they are a logistical problem, there are reports of increasing resistance, and they have been linked with, albeit rare, psychotic episodes in adolescents,” Jefferson said.
In contrast, handwashing, covering your mouth and nose if you sneeze, and staying at home if you’re sick are inexpensive, easy-to-implement strategies to prevent infection’s spread, the authors say.
Maldonado also suggested that parents work together with teachers and daycare providers to encourage regular hand washing in children to reduce respiratory disease transmission.
The UK’s National Health Service provided support for the research.
References:
Jefferson T, Foxlee R, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. The Cochrane Database of Systematic Reviews 2009, Issue 2.
Jefferson T, Demicheli V, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. The Cochrane Database of Systematic Reviews 2009, Issue 2.
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.